Display options
Cite
Guaraldi G, Rossotti R, Verucchi G, et al. Successful Pre- and Posttransplant Sofosbuvir-Based Anti-Hepatitis C Virus Treatment in Persons Living With Human Immunodeficiency Virus Infection. Open Forum Infect Dis. 2017;4(2):ofx065doi: 10.1093/ofid/ofx065.
Guaraldi, G., Rossotti, R., Verucchi, G., Tavio, M., Pasulo, L., Beghetto, B., Dolci, G., Nardini, G., Badia, L., Magliano, A., Moioli, M. C., Puoti, M. (2017). Successful Pre- and Posttransplant Sofosbuvir-Based Anti-Hepatitis C Virus Treatment in Persons Living With Human Immunodeficiency Virus Infection. Open forum infectious diseases, 4(2), ofx065. https://doi.org/10.1093/ofid/ofx065
Guaraldi, Giovanni, et al. "Successful Pre- and Posttransplant Sofosbuvir-Based Anti-Hepatitis C Virus Treatment in Persons Living With Human Immunodeficiency Virus Infection." Open forum infectious diseases vol. 4,2 (2017): ofx065. doi: https://doi.org/10.1093/ofid/ofx065
Guaraldi G, Rossotti R, Verucchi G, Tavio M, Pasulo L, Beghetto B, Dolci G, Nardini G, Badia L, Magliano A, Moioli MC, Puoti M. Successful Pre- and Posttransplant Sofosbuvir-Based Anti-Hepatitis C Virus Treatment in Persons Living With Human Immunodeficiency Virus Infection. Open Forum Infect Dis. 2017 May 29;4(2):ofx065. doi: 10.1093/ofid/ofx065. eCollection 2017. PMID: 28584851; PMCID: PMC5451199.
Copy Download .nbib Format: NLM
Share it on

Open Forum Infect Dis. 2017 May 29;4(2):ofx065. doi: 10.1093/ofid/ofx065. eCollection 2017.

Successful Pre- and Posttransplant Sofosbuvir-Based Anti-Hepatitis C Virus Treatment in Persons Living With Human Immunodeficiency Virus Infection.

Open forum infectious diseases

Giovanni Guaraldi, Roberto Rossotti, Gabriella Verucchi, Marcello Tavio, Luisa Pasulo, Barbara Beghetto, Giovanni Dolci, Giulia Nardini, Lorenzo Badia, Anna Magliano, Maria Cristina Moioli, Massimo Puoti,

Affiliations

  1. Infectious Diseases Departments of University of Modena, Italy.
  2. ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
  3. University of Bologna, Italy.
  4. Azienda Ospedaliera Universitaria Ospedali Riuniti, Ancona, Italy; and.
  5. Gastroenterology Department ASST Papa Giovanni XXIII, Bergamo, Italy.

PMID: 28584851 PMCID: PMC5451199 DOI: 10.1093/ofid/ofx065

Abstract

This retrospective study reports the data of sofosbuvir-based anti-hepatitis C virus treatment in 24 candidates and 24 recipients of liver transplantation coinfected with human immunodeficiency virus. Sustained virologic response was cumulatively 85% (90% and 100% in those treated with optimal schedules pre- and posttransplant, respectively).

Keywords: HCV; HIV; NS5A inhibitors; liver transplantation; sofosbuvir.

References

  1. J Hepatol. 2017 Jan;66(1):153-194 - PubMed
  2. Hepatol Res. 2016 Jul;46(8):829-32 - PubMed
  3. J Hepatol. 2015 Mar;62(3):701-11 - PubMed
  4. AIDS. 2016 Jan 2;30(1):93-8 - PubMed
  5. J Antimicrob Chemother. 2016 Nov;71(11):3195-3201 - PubMed
  6. J Hepatol. 2016 Oct;65(4):727-33 - PubMed
  7. Liver Transpl. 2016 Sep;22(9):1186-96 - PubMed
  8. Aliment Pharmacol Ther. 2016 Jun;43(12):1319-29 - PubMed
  9. Am J Transplant. 2014 May;14 (5):1129-35 - PubMed
  10. Clin Gastroenterol Hepatol. 2015 Nov;13(11):1993-2001.e1-2 - PubMed
  11. Gastroenterology. 2015 Sep;149(3):649-59 - PubMed

Publication Types